187 related articles for article (PubMed ID: 28293713)
21. High level of fecal calprotectin at age 2 months as a marker of intestinal inflammation predicts atopic dermatitis and asthma by age 6.
Orivuori L; Mustonen K; de Goffau MC; Hakala S; Paasela M; Roduit C; Dalphin JC; Genuneit J; Lauener R; Riedler J; Weber J; von Mutius E; Pekkanen J; Harmsen HJM; Vaarala O;
Clin Exp Allergy; 2015 May; 45(5):928-939. PubMed ID: 25758537
[TBL] [Abstract][Full Text] [Related]
22. Fecal calprotectin levels predict colorectal inflammation among patients with chronic diarrhea referred for colonoscopy.
Limburg PJ; Ahlquist DA; Sandborn WJ; Mahoney DW; Devens ME; Harrington JJ; Zinsmeister AR
Am J Gastroenterol; 2000 Oct; 95(10):2831-7. PubMed ID: 11051356
[TBL] [Abstract][Full Text] [Related]
23. Serum calprotectin as a biomarker for Crohn's disease.
Meuwis MA; Vernier-Massouille G; Grimaud JC; Bouhnik Y; Laharie D; Piver E; Seidel L; Colombel JF; Louis E;
J Crohns Colitis; 2013 Dec; 7(12):e678-83. PubMed ID: 23845231
[TBL] [Abstract][Full Text] [Related]
24. Serum ficolin-2 correlates worse than fecal calprotectin and CRP with endoscopic Crohn's disease activity.
Schaffer T; Schoepfer AM; Seibold F;
J Crohns Colitis; 2014 Sep; 8(9):1125-32. PubMed ID: 24636141
[TBL] [Abstract][Full Text] [Related]
25. Increasingly frequent diagnosis of acute gastrointestinal graft-versus-host disease after allogeneic hematopoietic cell transplantation.
Martin PJ; McDonald GB; Sanders JE; Anasetti C; Appelbaum FR; Deeg HJ; Nash RA; Petersdorf EW; Hansen JA; Storb R
Biol Blood Marrow Transplant; 2004 May; 10(5):320-7. PubMed ID: 15111931
[TBL] [Abstract][Full Text] [Related]
26. Application of proteomics to graft-versus-host disease: from biomarker discovery to potential clinical applications.
Presland RB
Expert Rev Proteomics; 2017 Nov; 14(11):997-1006. PubMed ID: 28974115
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of calprotectin level in intestinal content as an early marker for graft rejection.
Cagnola H; Scaravonati R; Cabanne A; Bianchi C; Gruz F; Errea A; Zambernardi A; Meier D; Chirdo F; Docena G; Gondolesi G; Rumbo M
Transplant Proc; 2010; 42(1):57-61. PubMed ID: 20172281
[TBL] [Abstract][Full Text] [Related]
28. Colonic graft-versus-host disease.
Ross WA; Couriel D
Curr Opin Gastroenterol; 2005 Jan; 21(1):64-9. PubMed ID: 15687887
[TBL] [Abstract][Full Text] [Related]
29. [Liver biopsy in the management of liver dysfunction after allogeneic hematopoietic stem-cell transplantation].
Chen H; Huang XJ; Liu KY; Xu LP; Wang H; Liu DH; Lu J; Lu DP
Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(43):3062-6. PubMed ID: 16324408
[TBL] [Abstract][Full Text] [Related]
30. The use of fecal calprotectin as a biomarker in gastrointestinal disease.
Burri E; Beglinger C
Expert Rev Gastroenterol Hepatol; 2014 Feb; 8(2):197-210. PubMed ID: 24345070
[TBL] [Abstract][Full Text] [Related]
31. Rapid Fecal Calprotectin Testing Predicts Mucosal Healing Better than C-reactive Protein and Serum Tumor Necrosis Factor α in Patients with Ulcerative Colitis.
Voiosu T; Benguş A; Bălănescu P; Dinu R; Voiosu A; Băicuş C; Mateescu B
Rom J Intern Med; 2015; 53(3):253-60. PubMed ID: 26710501
[TBL] [Abstract][Full Text] [Related]
32. Ferritin concentrations correlate to outcome of hematopoietic stem cell transplantation but do not serve as biomarker of graft-versus-host disease.
Großekatthöfer M; Güclü ED; Lawitschka A; Matthes-Martin S; Mann G; Minkov M; Peters C; Seidel MG
Ann Hematol; 2013 Aug; 92(8):1121-8. PubMed ID: 23604429
[TBL] [Abstract][Full Text] [Related]
33. Allogeneic stem cell transplantation as treatment for heavily treated, refractory acute graft-versus-host disease after HLA-mismatched stem cell transplantation.
Ikegame K; Yoshihara S; Taniguchi Y; Kaida K; Inoue T; Okada M; Taniguchi K; Hasei H; Tamaki H; Fujioka T; Kato R; Soma T; Ogawa H
Exp Hematol; 2011 Aug; 39(8):880-90. PubMed ID: 21689724
[TBL] [Abstract][Full Text] [Related]
34. Liver graft-versus-host disease after donor lymphocyte infusion for relapses of hematologic malignancies post allogeneic hematopoietic stem cell transplantation.
Ma SY; Au WY; Lie AK; Ng IO; Leung AY; Tse EW; Liang RH; Lau GK; Kwong YL
Bone Marrow Transplant; 2004 Jul; 34(1):57-61. PubMed ID: 15156162
[TBL] [Abstract][Full Text] [Related]
35. Calprotectin in ankylosing spondylitis--frequently elevated in feces, but normal in serum.
Klingberg E; Carlsten H; Hilme E; Hedberg M; Forsblad-d'Elia H
Scand J Gastroenterol; 2012 Apr; 47(4):435-44. PubMed ID: 22229862
[TBL] [Abstract][Full Text] [Related]
36. Anaerobic Antibiotics and the Risk of Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation.
Tanaka JS; Young RR; Heston SM; Jenkins K; Spees LP; Sung AD; Corbet K; Thompson JC; Bohannon L; Martin PL; Stokhuyzen A; Vinesett R; Ward DV; Bhattarai SK; Bucci V; Arshad M; Seed PC; Kelly MS
Biol Blood Marrow Transplant; 2020 Nov; 26(11):2053-2060. PubMed ID: 32682948
[TBL] [Abstract][Full Text] [Related]
37. Elevated fecal calprotectin is associated with gut microbial dysbiosis, altered serum markers and clinical outcomes in older individuals.
Heinzel S; Jureczek J; Kainulainen V; Nieminen AI; Suenkel U; von Thaler AK; Kaleta C; Eschweiler GW; Brockmann K; Aho VTE; Auvinen P; Maetzler W; Berg D; Scheperjans F
Sci Rep; 2024 Jun; 14(1):13513. PubMed ID: 38866914
[TBL] [Abstract][Full Text] [Related]
38. Salivary proteomic analysis and acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
Chiusolo P; Giammarco S; Fanali C; Bellesi S; Metafuni E; Sica S; Iavarone F; Cabras T; Messana I; Leone G; Castagnola M
Biol Blood Marrow Transplant; 2013 Jun; 19(6):888-92. PubMed ID: 23529013
[TBL] [Abstract][Full Text] [Related]
39. Calprotectin in spondyloarthritis: A systematic review and meta-analysis.
Ma Y; Fan D; Xu S; Deng J; Gao X; Guan S; Pan F
Int Immunopharmacol; 2020 Nov; 88():106948. PubMed ID: 32892074
[TBL] [Abstract][Full Text] [Related]
40. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
